Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients

Overview of attention for article published in Clinical Pharmacokinetics, May 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 3,733 followers.

RT @GrupoPKgen_SEFH: #Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in #Breas…

Reply Repost Favourite

RT @GrupoPKgen_SEFH: #Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in #Breas…

Reply Repost Favourite

#Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in #BreastCancer Patients https://t.co/eytnOLovRp

Reply Repost Favourite

RT @GrupoPKgen_SEFH: Exploiting PK Models of Tamoxifen and Endoxifen to Identify Factors Causing ⬇ Conc in Breast Cancer Patients https://…

Reply Repost Favourite

Exploiting PK Models of Tamoxifen and Endoxifen to Identify Factors Causing ⬇ Conc in Breast Cancer Patients https://t.co/lW4lV11uI6

Reply Repost Favourite